focus -WSS

focus

author：leisure time 2025-09-30 17:45:15 - browse：9758

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： European regulators recommend Amylyx's ALS drug be rejected

WSS

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Nick Jonas talks about managing diabetes along with his career

Takeaways from AdvaMed, the largest medical devices conference

European regulators consider appeal over Amylyx ALS drug

focus

focus

focus

Medicare details structure of new drug price negotiation program

Trump Jan. 6 attorney John Lauro is ex

Sports medicine is finally prioritizing gender equality

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Apple is now the first public company to be valued at $3 trillion

European regulators recommend Amylyx's ALS drug be rejected

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Illinois to ban advertising for guns allegedly marketed to kids and militants

Jerome Adams on the need for new antivirals for Covid

Bernie Sanders bashes nonprofit hospitals over their tax breaks

knowledge

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Trump Jan. 6 attorney John Lauro is ex

Moderna hits safety problems in bold bid to reinvent medicine

A revolution in caring for preterm infants

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Democratic lawmaker calls for 'well

hotspot

focus

Wikipedia

focus